These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 32902245)

  • 1. Efficient Lymph Node-Targeted Delivery of Personalized Cancer Vaccines with Reactive Oxygen Species-Inducing Reduced Graphene Oxide Nanosheets.
    Xu C; Hong H; Lee Y; Park KS; Sun M; Wang T; Aikins ME; Xu Y; Moon JJ
    ACS Nano; 2020 Oct; 14(10):13268-13278. PubMed ID: 32902245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic cell derived exosomes loaded neoantigens for personalized cancer immunotherapies.
    Li J; Li J; Peng Y; Du Y; Yang Z; Qi X
    J Control Release; 2023 Jan; 353():423-433. PubMed ID: 36470333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymph node-targeted neoantigen nanovaccines potentiate anti-tumor immune responses of post-surgical melanoma.
    Chu Y; Qian L; Ke Y; Feng X; Chen X; Liu F; Yu L; Zhang L; Tao Y; Xu R; Wei J; Liu B; Liu Q
    J Nanobiotechnology; 2022 Apr; 20(1):190. PubMed ID: 35418151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering a HemoMap Nanovaccine for Inducing Immune Responses against Melanoma.
    Dai H; Huang Y; Guo J; Li L; Ke Y; Cen L; Meng F; Chen X; Liu B; Qian X
    ACS Appl Mater Interfaces; 2022 Nov; 14(47):52634-52642. PubMed ID: 36383430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alum-functionalized graphene oxide nanocomplexes for effective anticancer vaccination.
    Wang X; Cao F; Yan M; Liu Y; Zhu X; Sun H; Ma G
    Acta Biomater; 2019 Jan; 83():390-399. PubMed ID: 30448435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomaterials-assisted construction of neoantigen vaccines for personalized cancer immunotherapy.
    Wu Y; Feng L
    Expert Opin Drug Deliv; 2023 Mar; 20(3):323-333. PubMed ID: 36634017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personalized combination nano-immunotherapy for robust induction and tumor infiltration of CD8
    Park KS; Nam J; Son S; Moon JJ
    Biomaterials; 2021 Jul; 274():120844. PubMed ID: 33962217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dual-adjuvant neoantigen nanovaccine loaded with imiquimod and magnesium enhances anti-tumor immune responses of melanoma.
    Chen X; Cen L; Liu Q; Chu Y; Feng X; Ke Y; Zhang Z; Dai H; Huang S; Liu B; Qian X
    Biomater Sci; 2022 Nov; 10(23):6740-6748. PubMed ID: 36285738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microdosed Lipid-Coated (67)Ga-Magnetite Enhances Antigen-Specific Immunity by Image Tracked Delivery of Antigen and CpG to Lymph Nodes.
    Ruiz-de-Angulo A; Zabaleta A; Gómez-Vallejo V; Llop J; Mareque-Rivas JC
    ACS Nano; 2016 Jan; 10(1):1602-18. PubMed ID: 26678549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A bi-adjuvant nanovaccine that potentiates immunogenicity of neoantigen for combination immunotherapy of colorectal cancer.
    Ni Q; Zhang F; Liu Y; Wang Z; Yu G; Liang B; Niu G; Su T; Zhu G; Lu G; Zhang L; Chen X
    Sci Adv; 2020 Mar; 6(12):eaaw6071. PubMed ID: 32206706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Potent Micron Neoantigen Tumor Vaccine GP-Neoantigen Induces Robust Antitumor Activity in Multiple Tumor Models.
    Jing Z; Wang S; Xu K; Tang Q; Li W; Zheng W; Shi H; Su K; Liu Y; Hong Z
    Adv Sci (Weinh); 2022 Aug; 9(24):e2201496. PubMed ID: 35712770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoantigen Vaccine Delivery for Personalized Anticancer Immunotherapy.
    Guo Y; Lei K; Tang L
    Front Immunol; 2018; 9():1499. PubMed ID: 30013560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Albumin/vaccine nanocomplexes that assemble in vivo for combination cancer immunotherapy.
    Zhu G; Lynn GM; Jacobson O; Chen K; Liu Y; Zhang H; Ma Y; Zhang F; Tian R; Ni Q; Cheng S; Wang Z; Lu N; Yung BC; Wang Z; Lang L; Fu X; Jin A; Weiss ID; Vishwasrao H; Niu G; Shroff H; Klinman DM; Seder RA; Chen X
    Nat Commun; 2017 Dec; 8(1):1954. PubMed ID: 29203865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Designer vaccine nanodiscs for personalized cancer immunotherapy.
    Kuai R; Ochyl LJ; Bahjat KS; Schwendeman A; Moon JJ
    Nat Mater; 2017 Apr; 16(4):489-496. PubMed ID: 28024156
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Yang J; Dong X; Li B; Chen T; Yu B; Wang X; Dou X; Peng B; Hu Q
    Front Bioeng Biotechnol; 2022; 10():1050077. PubMed ID: 36727039
    [No Abstract]   [Full Text] [Related]  

  • 16. Highly efficient nuclear delivery of anti-cancer drugs using a bio-functionalized reduced graphene oxide.
    Zheng XT; Ma XQ; Li CM
    J Colloid Interface Sci; 2016 Apr; 467():35-42. PubMed ID: 26773607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanotechnology-Based Approaches to Promote Lymph Node Targeted Delivery of Cancer Vaccines.
    He R; Zang J; Zhao Y; Dong H; Li Y
    ACS Biomater Sci Eng; 2022 Feb; 8(2):406-423. PubMed ID: 35005881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization with tumor neoantigens displayed on T7 phage nanoparticles elicits plasma antibody and vaccine-draining lymph node B cell responses.
    Shukla GS; Sun YJ; Pero SC; Sholler GS; Krag DN
    J Immunol Methods; 2018 Sep; 460():51-62. PubMed ID: 29906453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radionuclide (131)I labeled reduced graphene oxide for nuclear imaging guided combined radio- and photothermal therapy of cancer.
    Chen L; Zhong X; Yi X; Huang M; Ning P; Liu T; Ge C; Chai Z; Liu Z; Yang K
    Biomaterials; 2015 Oct; 66():21-8. PubMed ID: 26188609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Dendrimer Peptide (KK2DP7) Delivery System with Dual Functions of Lymph Node Targeting and Immune Adjuvants as a General Strategy for Cancer Immunotherapy.
    Zhang R; Tang L; Wang Y; Tian Y; Wu S; Zhou B; Dong C; Zhao B; Yang Y; Xie D; Yang L
    Adv Sci (Weinh); 2023 May; 10(15):e2300116. PubMed ID: 36950751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.